Borislava Mihaylova

Professor Borislava Mihaylova is a Professor of Health Economics and Lead of the Health Economics and Policy Research Unit at Queen Mary University of London’s Wolfson Institute of Population Health. She holds a DPhil in Public Health and Health Economics from the University of Oxford. Her academic background includes studies in Computer Science and Finance (Technical University-Sofia, Bulgaria) and Health Economics (University of York, UK).

Her research focuses on evaluating the cost-effectiveness of healthcare policies, treatments, and prevention strategies, with a particular emphasis on cardiovascular disease, chronic kidney disease, and public health interventions. She develops evaluative frameworks using large-scale population health data to inform targeted policy decisions. Key areas include modeling health outcomes, assessing resource utilization, and analyzing disparities in treatment benefits across demographic and risk groups.

Professor Mihaylova has contributed to major studies on statins, blood pressure treatments, and niacin, influencing clinical guidelines. Her work bridges methodological advancements in health economics with real-world health policy applications. She teaches graduate courses, including the MSc module “Health Economic Analyses” and leads the “Effective and Efficient Evaluation” theme in the Wellcome Trust PhD Programme in Science.

Her supervision includes PhD students researching asthma management strategies, digital health technologies, and IBD self-management. She collaborates with interdisciplinary teams on initiatives like the NIHR School for Primary Care Research and the Cholesterol Treatment Trialists’ Collaboration.